Recent

% | $
Quotes you view appear here for quick access.

Gentium AŞ Message Board

  • chrisgoldmannyc chrisgoldmannyc Apr 16, 2010 2:45 PM Flag

    GENT Research Part 1

    Hi everyone,

    I'm having trouble finding very much financial information related to this company. The stock has been flying up without very much information to support it. It looks like they make four products. Yahoo financial indicates that their revenue has improved. However, it's conerning that there is no info on what there actual EPS is. Let's join together and try to understand what this company's future prospects are.

    Thanks,
    Chris


    http://www.gentium.it/Homepage.aspx


    http://seekingalpha.com/article/192315-medivation-pfizer-disappointed-over-drug-failure-biotech-s-latest-mishaps?source=yahoo

    Gentium (GENT) announced a reorganization including management changes in an effort to consolidate its resources and operations. The move follows a license agreement with Sigma-Tau that provides Gentium with up to $15 million in non-dilutive funding. Gentium will close its New York office and consolidate corporate activities and the executive management team within its headquarters in Italy. Gary Gemignani, executive vice-president and CFO since 2006, will be leaving the company March 31, but will provide transitional services through a consulting agreement. Khalid Islam, currently Gentium's chairman and interim CEO, will assume the role of CEO on a full-time basis. In addition, Salvatore Calabrese, Gentium's current vice president of finance, has been promoted to senior vice president of finance. The closure of the New York office is expected to result in one-time payments of approximately $1.5 million and is anticipated to yield annual cost savings of approximately $1.3 million.